NCT06392711View on ClinicalTrials.gov

Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia

PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 4, 2024

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions
XerostomiaGraft-versus-host-diseaseSjogren's Disease
Interventions
BIOLOGICAL

Mesenchymal Stromal Cells (MSC) Dose Level 0

10 (8-12) x 10\^6 MSCs

BIOLOGICAL

Mesenchymal Stromal Cells (MSC) Dose Level 1

20 (16-24) x 10\^6

Trial Locations (1)

53705

RECRUITING

University of Wisconsin, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER